TRCT
AFJK

Tower Research Capital (TRC)’s Aimei Health Technology Co AFJK Stock Holding History

Tower Research Capital (TRC)’s Portfolio AFJK Stock Details AFJK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-48
Closed -$514 – 5138
2024
Q4 		$514 Buy
48
+34
+243% +$360 ﹤0.01% 5249
2024
Q3 		$147 Buy
+14
New +$146 ﹤0.01% 5465

Other funds holding AFJK

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
HCI
Harraden Circle Investments New York $499M AUM 19.71% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return

Tower Research Capital (TRC)'s AFJK Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Aimei Health Technology Co (AFJK) in Q1 2025, closing a stake of 48 shares — an estimated $514 sold.

Tower Research Capital (TRC) first reported a position in AFJK in Q3 2024 and held it in 2 quarters. The position peaked at $514 in Q4 2024. 16 funds tracked by Wall St. Rank hold AFJK as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Aimei Health Technology Co position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 48 Aimei Health Technology Co shares in Q1 2025, an estimated $514.
  • Tower Research Capital (TRC) first reported a position in Aimei Health Technology Co in Q3 2024 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Aimei Health Technology Co position peaked at $514 in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.